ALNYLAM PHARMACEUTICALS, INC.
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Ticker / security symbols
- ALNY [1]
- Listing exchanges
- Nasdaq [1]
- SEC industry
- Pharmaceutical Preparations [1]
- Business sectors
- pharmaceutical industry [2]
- Company / filing name
- ALNYLAM PHARMACEUTICALS, INC. [1]
- Headquarters location
- Cambridge [2]
- Business address
- 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, 02142 [1]
- Founded
- 2002 [2]
- Legal form
- Delaware corporation [2]
- Official website
- www.alnylam.com ↗ [2]
- Fiscal year end
- December 31 (SEC record) [1]
- ISIN (reported securities)
- US02043Q1076 [2]
- CIK
- 0001178670 [1]
- SIC code
- 2834 [1]
- Country in background record
- United States [2]
Company positioning and business
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. [3]
Background text: Wikipedia contributors, Alnylam Pharmaceuticals. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Financial year, securities and disclosures
The SEC submissions record gives ALNYLAM PHARMACEUTICALS, INC. a fiscal year end of 1231 (MMDD). Individual filings below identify their own reporting period; the filing date is the publication event, not the financial year end. [1]
Listed securities: ALNY (Nasdaq). Multiple symbols may represent different share classes or securities of the same registrant. [4]
History and key events
Financial results and regulatory disclosures
Annual, quarterly and current reports from the collected SEC record. Insider Forms 4 and 144 are excluded. This is a selected list, not a live filing feed.
Source-verified relationships
Companies in the same industry
Comparison candidates share the SEC SIC classification 2834. This does not imply ownership, partnership or trading relationships.
Related entities and concepts
Frequently asked questions
When was ALNYLAM PHARMACEUTICALS, INC. founded?
Founded: 2002. The linked source provides the background record. [2]
Where is the headquarters of ALNYLAM PHARMACEUTICALS, INC.?
Headquarters location: Cambridge. The linked source provides the background record. [2]
Which business sectors are recorded for ALNYLAM PHARMACEUTICALS, INC.?
Business sectors: pharmaceutical industry. The linked source provides the background record. [2]
ALNYLAM PHARMACEUTICALS, INC. relationship map
Select a node to inspect its relationship and source.
2 verified direct relationships. Industry peers are not relationship edges.
Sources and review dates
- SEC — ALNYLAM PHARMACEUTICALS, INC. filing identity and securities ↗
- Wikidata — company background record (CC0) ↗
- Wikipedia contributors — Alnylam Pharmaceuticals (CC BY-SA 4.0) ↗
- SEC securities directory ↗
- Company chronology / filing ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.